#trending

 

Eriq La Salle is returning to a small screen near you. The Hollywood Reporter states that La Salle will recur as neuropsychiatrist Evan Morrison (yes, another doctor), a medical detective on the new CBS medical drama A Gifted Man. Currently directing an episode of CW’s new action drama Ringer, HR reports that La Salle may direct an episode of A Gifted Man as well.

Born Dante Smith, he became known the world over as Mos Def, Black Star counterpart, and accomplished actor. Now he says it’s time to part ways with this title, claiming, “I didn’t want to have to deal with having any moniker or any separation between the self that I see [and what people refer to me as]… Mos Def is a name that I cultivated over the years, and it’s a name that the streets taught me,” he says. “A figure of speech that was given to me by the culture and by my environment. I feel I’ve done quite a bit with that name. It’s time to expand and move on.”

Dig this to learn the new moniker of the artist almost formerly known as Mos Def, and more…

Meanwhile, things aren’t looking so good for Wesley Snipes. A three-judge federal appeals court panel today nixed jailed action star Wesley Snipes’ bid for a new trial on the grounds of possible juror misconduct in his February 2008 tax trial, Forbes reports. The actor has since been convicted on three misdemeanor counts of willful failure to file income tax returns.

According to Access Atlanta, Snipes’ defense lawyers contended they received emails from former jurors reporting misconduct among other members of the panel. One of the former jurors said in the email that three other jurors acknowledged they had determined Snipes was guilty before the trial began. Nonetheless, the ruling was upheld on Tuesday, finding that there wasn’t “strong, substantial and incontrovertible evidence” that would warrant a new trial giving the former action hero no choice but to serve out his 3 year sentence at a Pennsylvania correctional facility that commenced in December of last year.

Tags:
Like Us On Facebook Follow Us On Twitter